பச்சை குறுக்கு கார்ப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Green Cross two Kosdaq-listed cell therapy arms to merge Green Cross expects the merger to give boost to contract manufacturing business By Green　Cross s　Hwasun　factory　in　South　Jeolla　Province,　South　Korea South Korea s pharmaceutical group Green Cross Corp., or GC Pharma, will combine its two cell therapy developers listed on the junior Kosdaq market in efforts to scale up and sharpen its focus on the growing cell-based therapy market.  The combination of GC LabCell Corp. and GC Cell Corp, in which GC Pharma is top shareholders, is also aimed at accelerating their penetration into the contract development and manufacturing organization (CDMO) segment, according to the companies regulatory filings on July 16. A CDMO develops and manufactures drugs for other pharmaceutical companies on a contract basis.

Ch ungch ong namdoSouth koreaSouth koreanGc labcell corpGreen cross corpBank antibodyGc cell corpCoalition for epidemic preparedness innovationsGreen crossMerck sharpEpidemic preparedness innovationsKorea economicதெற்கு கொரியாதெற்கு கொரியன்பச்சை குறுக்கு கார்ப்கூட்டணி க்கு பெருவாரியாக பரவும் தொற்று நோய் ப்ரிப்யாரெட்நெஸ் புதுமைகள்